| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 26 |
| 1 | PACLITAXEL | 23 |
| 2 | PACLITAXEL (AIBUMIN-BOUND) | 23 |
| 3 | NIRAPARIB | 11 |
| 4 | DOXORUBICIN | 10 |
| 5 | BEVACIZUMAB | 9 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 8 |
| 7 | OLAPARIB | 4 |
| 8 | IMATINIB MESYLATE | 3 |
| 9 | CISPLATIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAFOLACIANINE INJECTION | 1 | 0.0159 |
| 1 | TREOSULFAN | 2 | 0.0007 |
| 2 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 3 | NIRAPARIB | 11 | 0.0005 |
| 4 | DECITABINE | 2 | 0.0005 |
| 5 | TOPOTECAN HYDROCHLORIDE | 1 | 0.0004 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 8 | 0.0002 |
| 7 | PACLITAXEL | 23 | 0.0002 |
| 8 | CARBOPLATIN | 26 | 0.0002 |
| 9 | OLAPARIB | 4 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 1 | Microtubule Inhibitor [EPC] | 23 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 27 | 0.0001 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 | 0.0000 |
| 4 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |